Calpain inhibition reduces axolemmal leakage in traumatic axonal injury

Molecules

Volumn 14, Issue 12, 2009, Pages 5115-5123

  Czeiter, Endre ^a   Büki, András ^a   Bukovics, Péter ^a   Farkas, Orsolya ^a   Pál, József ^a   Kövesdi, Erzsébet ^a   Dóczi, Tamás ^a   Sándor, János ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Calpain; MDL 28170; Traumatic axonal injury; Traumatic brain injury

Indexed keywords

CALPAIN; CALPAIN INHIBITOR III; CYSTEINE PROTEINASE INHIBITOR; DIPEPTIDE;

ANIMAL; ARTICLE; DRUG ANTAGONISM; NERVE FIBER; RAT; WISTAR RAT;

ANIMALS; AXONS; CALPAIN; CYSTEINE PROTEINASE INHIBITORS; DIPEPTIDES; RATS; RATS, WISTAR;

EID: 73849113384     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14125115     Document Type: Article

References (28)

1. Gennarelli, T.A.; Thibault, L.E.; Adams, J.H.; Graham, D.I.; Thompson, C.J.; Marcincin, R.P. Diffuse axonal injury and traumatic coma in the primate. Ann. Neurol. 1982, 12, 564-574.
2. Povlishock, J.T.; Becker, D.P.; Cheng, C.L.; Vaughan, G.W. Axonal change in minor head injury. J. Neuropathol. Exp. Neurol. 1983, 42, 225-242.
3. Povlishock, J.T. Traumatically induced axonal injury: pathogenesis and pathobiological implications. Brain Pathol. 1992, 2, 1-12.
4. Maxwell, W.L.; Povlishock, J.T.; Graham, D.L. A mechanistic analysis of nondisruptive axonal injury: a review. J. Neurotrauma. 1997, 14, 419-440.
5. Povlishock, J.T.; Stone, J.R., Traumatic axonal injury. In Head trauma: Basic, Preclinical and Clinical Directions; Miller, E., Newcomb-Fernandez, J.K., Hayes, R.L., Eds.; John Wiley and Sons: New York, NY, USA, 2001; pp. 281-301.
6. Stone, J.R.; Okonkwo, D.O.; Dialo, A.O.; Rubin, D.G.; Mutlu, L.K.; Povlishock, J.T.; Helm, G.A. Impaired axonal transport and altered axolemmal permeability occur in distinct populations of damaged axons following traumatic brain injury. Exp. Neurol. 2004, 190, 59-69.
7. Carragher, N.O. Calpain inhibition: a therapeutic strategy targeting multiple disease states. Curr. Pharm. Des. 2006, 12, 615-638.
8. Czogalla, A.; Sikorski, A.F. Spectrin and calpain: a 'target' and a 'sniper' in the pathology of neuronal cells. Cell. Mol. Life Sci. 2005, 62, 1913-1924.
9. Hong, S.C.; Goto, Y.; Lanzino, G.; Soleau, S.; Kassell, N.F.; Lee, K.S. Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke 1994, 25, 663-669.
10. Saatman, K.E.; Bozyczko-Coyne, D.; Marcy, V.; Siman, R.; McIntosh, T.K. Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J. Neuropathol. Exp. Neurol. 1996, 55, 850-860.
11. Banik, N.L.; Shields, D.C.; Ray, S.; Davis, B.; Matzelle, D.; Wilford, G.; Hogan, E.L. Role of calpain in spinal cord injury: effects of calpain and free radical inhibitors. Ann. N. Y. Acad. Sci. 1998, 844, 131-137.
12. Araujo Couto, L.; Sampaio Narciso, M.; Hokoc, J.N.; Blanco Martinez, A.M. Calpain inhibitor 2 prevents axonal degeneration of opossum optic nerve fibers. J. Neurosci. Res. 2004, 77, 410-419.
13. Zhang, S.X.; Bondada, V.; Geddes, J.W. Evaluation of conditions for calpain inhibition in the rat spinal cord: effective postinjury inhibition with intraspinal MDL28170 microinjection. J. Neurotrauma. 2003, 20, 59-67.
14. Posmantur, R.; Kampfl, A.; Siman, R.; Liu, J.; Zhao, X.; Clifton, G.L.; Hayes, R.L. A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat. Neuroscience 1997, 77, 875-888.
15. Pettus, E.H.; Christman, C.W.; Giebel, M.L.; Povlishock, J.T. Traumatically induced altered membrane permeability: its relationship to traumatically induced reactive axonal change. J. Neurotrauma 1994, 11, 507-522.
16. Pettus, E.H.; Povlishock, J.T. Characterization of a distinct set of intra-axonal ultrastructural changes associated with traumatically induced alteration in axolemmal permeability. Brain Res. 1996, 722, 1-11.
17. Büki, A.; Siman, R.; Trojanowski, J.Q.; Povlishock, J.T. The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury. J. Neuropathol. Exp. Neurol. 1999, 58, 365-375.
18. Cardali, S.; Maugeri, R. Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury. J. Neurosurg. Sci. 2006, 50, 25-31.
19. Pineda, J.A.; Lewis, S.B.; Valadka, A.B.; Papa, L.; Hannay, H.J.; Heaton, S.C.; Demery, J.A.; Liu, M.C.; Aikman, J.M.; Akle, V.; Brophy, G.M.; Tepas, J.J.; Wang, K.K.; Robertson, C.S.; Hayes, R.L. Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. J. Neurotrauma. 2007, 24, 354-366.
20. Buki, A.; Farkas, O.; Doczi, T.; Povlishock, J.T. Preinjury administration of the calpain inhibitor MDL-28170 attenuates traumatically induced axonal injury. J. Neurotrauma. 2003, 20, 261-268.
21. Foda, M.A.; Marmarou, A. A new model of diffuse brain injury in rats. Part II: Morphological characterization. J. Neurosurg. 1994, 80, 301-313.
22. Markgraf, C.G.; Velayo, N.L.; Johnson, M.P.; McCarty, D.R.; Medhi, S.; Koehl, J.R.; Chmielewski, P.A.; Linnik, M.D. Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats. Stroke 1998, 29, 152-158.
23. Okonkwo, D.O.; Pettus, E.H.; Moroi, J.; Povlishock, J.T. Alteration of the neurofilament sidearm and its relation to neurofilament compaction occurring with traumatic axonal injury. Brain Res. 1998, 784, 1-6.
24. McCracken, E.; Hunter, A.J.; Patel, S.; Graham, D.I.; Dewar, D. Calpain activation and cytoskeletal protein breakdown in the corpus callosum of head-injured patients. J. Neurotrauma. 1999, 16, 749-761.
25. Farkas, O.; Polgár, B.; Szekeres-Barthó, J.; Dóczi, T.; Povlishock, J.T.; Büki, A. Spectrin breakdown products in the cerebrospinal fluid in severe head injury - preliminary observations. Acta Neurochir. 2005, 147, 855-861.
26. Lee, K.S.; Yanamoto, H.; Fergus, A.; Hong, S.C.; Kang, S.D.; Cappelletto, B.; Toyoda, T.; Kassell, N.F.; Bavbek, M.; Kwan, A.L. Calcium-activated proteolysis as a therapeutic target in cerebrovascular disease. Ann. N. Y. Acad. Sci. 1997, 825, 95-103.
27. Newcomb-Fernandez, J.K.; Zhao, X.; Pike, B.R.; Wang, K.K.; Kampfl, A.; Beer, R.; DeFord, S.M.; Hayes, R.L. Concurrent assessment of calpain and caspase-3 activation after oxygen-glucose deprivation in primary septo-hippocampal cultures. J. Cereb. Blood Flow Metab. 2001, 21, 1281-1294.
28. Saatman, K.E.; Zhang, C.; Bartus, R.T.; McIntosh, T.K. Behavioral efficacy of posttraumatic calpain inhibition is not accompanied by reduced spectrin proteolysis, cortical lesion, or apoptosis. J. Cereb. Blood Flow Metab. 2000, 20, 66-73